Understanding how the microbiome affects cancer development and treatment
Official title: Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome Relationships
Funded at Graduate School of Public Health and Health Policy · NIH-10990882 · Data updated 2026-11-12
This study is looking at how the tiny germs in our bodies might affect cancer growth and how well treatments like immunotherapy work, so that patients can better understand how their own germs could influence their cancer care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Graduate School of Public Health and Health Policy NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 1, 2019 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $427,476 |
| NIH project number | 2R01CA230551-06 |
| Project ID | NIH-10990882 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with various types of cancer, particularly those undergoing immunotherapy.
✕Less likely to help
Patients with non-cancerous conditions or those not undergoing any form of treatment may not receive direct benefits from this research.
What this research studies
This research investigates the relationship between the microbiome and cancer, focusing on how changes in microbial communities may influence cancer progression and response to treatments like immunotherapy. By creating and enhancing databases that compile public microbiome data, the project aims to facilitate the analysis of microbial signatures associated with various cancers. Patients may benefit from improved understanding of how their microbiome could affect their cancer treatment outcomes. The research employs advanced data curation and analysis techniques to ensure high-quality, accessible information for further studies.
Why it matters
Potential benefit: If successful, this research could lead to personalized cancer treatments based on individual microbiome profiles.
How similar studies have gone: Previous research has shown promising results in understanding the microbiome's role in cancer, indicating that this approach could yield valuable insights.
Where this research is happening
-
Graduate School of Public Health and Health Policy
New York, United States Active
Researchers
- Principal investigator: Waldron, Levi — Graduate School of Public Health and Health Policy
- Study coordinator: Waldron, Levi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.